These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 12151869)
1. Emerging concepts in the pathophysiology and treatment of obesity-associated hypertension. Engeli S; Sharma AM Curr Opin Cardiol; 2002 Jul; 17(4):355-9. PubMed ID: 12151869 [TBL] [Abstract][Full Text] [Related]
2. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME Circ Res; 2015 Mar; 116(6):991-1006. PubMed ID: 25767285 [TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of obesity hypertension. Hall JE Curr Hypertens Rep; 2000 Apr; 2(2):139-47. PubMed ID: 10981140 [TBL] [Abstract][Full Text] [Related]
4. Factors that influence the risk of hypertension in obese individuals. Coatmellec-Taglioni G; Ribière C Curr Opin Nephrol Hypertens; 2003 May; 12(3):305-8. PubMed ID: 12698070 [TBL] [Abstract][Full Text] [Related]
5. Leptin and hypertension in obesity. Bravo PE; Morse S; Borne DM; Aguilar EA; Reisin E Vasc Health Risk Manag; 2006; 2(2):163-9. PubMed ID: 17319461 [TBL] [Abstract][Full Text] [Related]
6. Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity. Hall JE Hypertension; 1994 Mar; 23(3):381-94. PubMed ID: 8125566 [TBL] [Abstract][Full Text] [Related]
7. Pathophysiology and treatment of obesity hypertension. Wofford MR; Hall JE Curr Pharm Des; 2004; 10(29):3621-37. PubMed ID: 15579059 [TBL] [Abstract][Full Text] [Related]
8. The kidney, hypertension, and obesity. Hall JE Hypertension; 2003 Mar; 41(3 Pt 2):625-33. PubMed ID: 12623970 [TBL] [Abstract][Full Text] [Related]
9. Role of adipose tissue for cardiovascular-renal regulation in health and disease. Engeli S; Sharma AM Horm Metab Res; 2000; 32(11-12):485-99. PubMed ID: 11246814 [TBL] [Abstract][Full Text] [Related]
10. Role of sympathetic nervous system and neuropeptides in obesity hypertension. Hall JE; Brands MW; Hildebrandt DA; Kuo J; Fitzgerald S Braz J Med Biol Res; 2000 Jun; 33(6):605-18. PubMed ID: 10829088 [TBL] [Abstract][Full Text] [Related]
12. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications. Kalil GZ; Haynes WG Hypertens Res; 2012 Jan; 35(1):4-16. PubMed ID: 22048570 [TBL] [Abstract][Full Text] [Related]
13. [Hypertension in obese patients: Pathophysiology and management]. Girerd X; Hansel B Presse Med; 2009 Apr; 38(4):609-13. PubMed ID: 19233604 [TBL] [Abstract][Full Text] [Related]
14. Impact of the obesity epidemic on hypertension and renal disease. Hall JE; Jones DW; Kuo JJ; da Silva A; Tallam LS; Liu J Curr Hypertens Rep; 2003 Oct; 5(5):386-92. PubMed ID: 12948431 [TBL] [Abstract][Full Text] [Related]
15. Sympathetic nervous system and insulin resistance: from obesity to diabetes. Esler M; Rumantir M; Wiesner G; Kaye D; Hastings J; Lambert G Am J Hypertens; 2001 Nov; 14(11 Pt 2):304S-309S. PubMed ID: 11721888 [TBL] [Abstract][Full Text] [Related]
17. Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases. Balasubramanian P; Hall D; Subramanian M Geroscience; 2019 Feb; 41(1):13-24. PubMed ID: 30519806 [TBL] [Abstract][Full Text] [Related]
18. The sympathetic nervous system in obesity hypertension. Lohmeier TE; Iliescu R Curr Hypertens Rep; 2013 Aug; 15(4):409-16. PubMed ID: 23677623 [TBL] [Abstract][Full Text] [Related]
19. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). Landsberg L J Hypertens; 2001 Mar; 19(3 Pt 2):523-8. PubMed ID: 11327624 [TBL] [Abstract][Full Text] [Related]
20. Obesity hypertension: role of leptin and sympathetic nervous system. Hall JE; Hildebrandt DA; Kuo J Am J Hypertens; 2001 Jun; 14(6 Pt 2):103S-115S. PubMed ID: 11411745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]